Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma
Clinical trial NCT02388906 · COMPLETED
Trial details
- NCT number
- NCT02388906
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-16
- Primary completion
- 2018-11-26
- Enrollment
- 906
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.